HRT Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2M | Buy |
131,087
+98,267
| +299% | +$39.8M | 0.23% | 35 |
|
|
2025
Q1 | $16.3M | Buy |
32,820
+11,173
| +52% | +$5.56M | 0.1% | 124 |
|
|
2024
Q4 | $11.3M | Sell |
21,647
-25,877
| -54% | -$13.5M | 0.06% | 163 |
|
|
2024
Q3 | $29.4M | Sell |
47,524
-108,379
| -70% | -$67M | 0.15% | 60 |
|
|
2024
Q2 | $86.2M | Buy |
+155,903
| New | +$86.2M | 0.48% | 19 |
|
|
2024
Q1 | – | Sell |
-5,373
| Closed | -$2.85M | – | 2905 |
|
|
2023
Q4 | $2.85M | Sell |
5,373
-120,158
| -96% | -$63.8M | 0.02% | 480 |
|
|
2023
Q3 | $63.5M | Buy |
125,531
+94,688
| +307% | +$47.9M | 0.63% | 21 |
|
|
2023
Q2 | $16.1M | Buy |
+30,843
| New | +$16.1M | 0.15% | 93 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2989 |
|
|
2022
Q4 | – | Sell |
-15,283
| Closed | -$7.75M | – | 2932 |
|
|
2022
Q3 | $7.75M | Buy |
+15,283
| New | +$7.75M | 0.08% | 175 |
|
|
2021
Q3 | – | Sell |
-83,741
| Closed | -$42.2M | – | 3505 |
|
|
2021
Q2 | $42.2M | Buy |
83,741
+73,212
| +695% | +$36.9M | 0.39% | 34 |
|
|
2021
Q1 | $4.81M | Buy |
+10,529
| New | +$4.81M | 0.05% | 256 |
|
|
2020
Q3 | – | Sell |
-17,110
| Closed | -$6.2M | – | 2238 |
|
|
2020
Q2 | $6.2M | Buy |
17,110
+2,943
| +21% | +$1.07M | 0.19% | 92 |
|
|
2020
Q1 | $4.02M | Buy |
+14,167
| New | +$4.02M | 0.26% | 71 |
|
|
2019
Q4 | – | Sell |
-6,364
| Closed | -$1.85M | – | 1551 |
|
|
2019
Q3 | $1.85M | Buy |
+6,364
| New | +$1.85M | 0.09% | 141 |
|